NCT07024589View on ClinicalTrials.gov

First-in-Human Trial of Oral AN2-502998

PHASE1RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 4, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

AN2-502998

Oral Capsule

DRUG

Placebo

Oral Capsule

Trial Locations (1)

3004

RECRUITING

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

AN2 Therapeutics, Inc

INDUSTRY

NCT07024589 - First-in-Human Trial of Oral AN2-502998 | Biotech Hunter | Biotech Hunter